Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: The MIRAGE trial.

Authors: Alberto Bosio, Giulia Cerretti, Marta Padovan, Paola Del Bianco, Maurizio Polano, Susanna Mandruzzato, Stefano Indraccolo, Renzo Manara, Giovanni Librizzi, Mario Caccese, Martina Corrà, Marta Maccari, Sara Lonardi, Gian Luca De Salvo, Giuseppe Lombardi

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2102

Source: Full article

---

Abstract

TPS2102